1. Assessing user fees under the Generic Drug User Fee Amendments of 2017 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Industry -- legislation & jurisprudenceDrugs, Generic -- economicsUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration